Printer Friendly
The Free Library
14,538,305 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Hyal Pharmaceutical Announcement.


MISSISSAUGA, Ontario--(BUSINESS WIRE)--March 15, 1999--Hyal Pharmaceutical Corporation (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 BB:HYALF)(TSE See Tokyo Stock Exchange.

TSE

1. See Tokyo Stock Exchange (TSE).

2. See Toronto Stock Exchange (TSE).
:HPC (Handheld PC) A palmtop computer that weighs less than one pound and runs specialized versions of popular applications. Microsoft coined the term for its Windows CE operating system, which is an abbreviated version of Windows. See Pocket PC. ) announced today that Fujisawa Healthcare Inc. of Deerfield, Ill. has decided not to enter into a licencing arrangement for Solarase(TM) for North America.

Hyal Pharmaceutical Corporation is a drug delivery development company engaged in research and development utilizing its proprietary Hyaluronan Induced Targeting (HIT(TM)) Technology and Hyaluronan Improved Liposome liposome (lī`pəsōm', lĭp`ə–), microscopic, fluid-filled pouch whose walls are made of layers of phospholipids identical to the phospholipids that make up cell membranes.  Technology (HILT(TM)). The Company's strategy is to commercialize its developments by outlicensing on a global basis.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:Mar 15, 1999
Words:82
Previous Article:Allied Telesyn Further Enhances High Performance Layer 2/Layer 3 Ethernet LAN Switching.
Next Article:Murphy Oil Announces 1998 Reserve Replacement and 1999 Capital Program.



Related Articles
Hyal Shareholders Defeat Recapitalization Plan.
Hyal Signs Letter Of Intent With Fujisawa For Rights To Solarase.
Hyal Pharmaceutical Announcement.
Hyal Pharmaceutical Announcement.
Hyal Pharmaceutical Announcement.
Hyal Pharmaceutical Corporation Announces Transaction With SkyePharma PLC.
Hyal Pharmaceutical Reports Financial Results For The Year Ended December 31, 1998.
Hyal Pharmaceutical Reports Financial Results for The Three Months Ended March 31, 1999.
Pharmacies adjust to new realities.(Brief Article)(Statistical Data Included)
Kyorin to Reorganize Its Group Businesses in October.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles